CVS Health Corporation (NYSE:CVS), also known as CVS Pharmacy, just announced that customers in the Greater Boston area can enroll in CarePass. CarePass is CVS’s new pilot membership program that adds to its popular ExtraCare …
Colorado-based biopharmaceutical company, Clovis Oncology (Nasdaq:CLVS) has received approval from the United States Food and Drug Administration (FDA) today for the company’s ovarian cancer maintenance treatment, RUBRACA (rucaparib).
Stock of the biotechnology company Incyte Corporation (Nasdaq:INCY) have taken a nosedive today after the company released the failed results of their cancer research Phase 3 ECHO-301/KEYNOTE-252 study.
Glaukos Corp. (NASDAQ:$GKOS) is a medical device manufacturer with an eye on glaucoma. The company’s shares are plundering 16.7% today, after management made some adjustments to this year’s total revenue expectations.